» Articles » PMID: 8254743

Identification of the Threonine Phosphorylation Sites on the Polyomavirus Major Capsid Protein VP1: Relationship to the Activity of Middle T Antigen

Overview
Journal J Virol
Date 1994 Jan 1
PMID 8254743
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Phosphorylation of the polyomavirus major capsid protein VP1 was examined after in vivo 32P labeling of virus-infected cells. Two phosphorylated peptide fragments of VP1 were identified by protease digestion, high-performance liquid chromatography purification, mass spectrometry, and N-terminal sequencing. The peptides from residues 58 to 78 and residues 153 to 173 were phosphorylated on threonine. Site-directed mutations were introduced at these threonine sites, and mutant viruses were reconstructed. A threonine-to-glycine change at residue 63 (mutant G63) and a threonine-to-alanine change at residue 156 (mutant A156) resulted in viruses defective in phosphorylation of the respective peptides after in vivo labeling. Growth of the mutant G63 virus was similar to that of the wild-type virus, but the mutant A156 was inefficient in assembly of 240S viral particles. Polyomavirus nontransforming host range (hr-t) mutants are defective in VP1 threonine phosphorylation when grown in nonpermissive cells (R. L. Garcea, K. Ballmer-Hofer, and T. L. Benjamin, J. Virol. 54:311-316, 1985). Proteolytic mapping of VP1 peptides after in vivo labeling from hr-t mutant virus infections demonstrated that both residues T-63 and T-156 were affected. These results suggest that the block in virion assembly in hr-t mutant viruses is associated with a defect in phosphorylation of threonine 156.

Citing Articles

Assembly of Structurally Simple Icosahedral Viruses.

Lopez-Bueno A, Gil-Ranedo J, Almendral J Subcell Biochem. 2024; 105:403-430.

PMID: 39738953 DOI: 10.1007/978-3-031-65187-8_11.


BK polyomavirus subtype III in a pediatric renal transplant patient with nephropathy.

Kapusinszky B, Chen S, Sahoo M, Lefterova M, Kjelson L, Grimm P J Clin Microbiol. 2013; 51(12):4255-8.

PMID: 24048534 PMC: 3838085. DOI: 10.1128/JCM.01801-13.


Quantitative measurement of human papillomavirus type 16 e5 oncoprotein levels in epithelial cell lines by mass spectrometry.

Sahab Z, Sudarshan S, Liu X, Zhang Y, Kirilyuk A, Kamonjoh C J Virol. 2012; 86(17):9465-73.

PMID: 22740411 PMC: 3416135. DOI: 10.1128/JVI.01032-12.


Lessons in signaling and tumorigenesis from polyomavirus middle T antigen.

Fluck M, Schaffhausen B Microbiol Mol Biol Rev. 2009; 73(3):542-63, Table of Contents.

PMID: 19721090 PMC: 2738132. DOI: 10.1128/MMBR.00009-09.


Lessons from polyoma middle T antigen on signaling and transformation: A DNA tumor virus contribution to the war on cancer.

Schaffhausen B, Roberts T Virology. 2008; 384(2):304-16.

PMID: 19022468 PMC: 2676342. DOI: 10.1016/j.virol.2008.09.042.


References
1.
Hirt B . Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol. 1967; 26(2):365-9. DOI: 10.1016/0022-2836(67)90307-5. View

2.
Freund R, Garcea R, Sahli R, BENJAMIN T . A single-amino-acid substitution in polyomavirus VP1 correlates with plaque size and hemagglutination behavior. J Virol. 1991; 65(1):350-5. PMC: 240524. DOI: 10.1128/JVI.65.1.350-355.1991. View

3.
BENJAMIN T . Host range mutants of polyoma virus. Proc Natl Acad Sci U S A. 1970; 67(1):394-9. PMC: 283217. DOI: 10.1073/pnas.67.1.394. View

4.
Hattori J, Carmichael G, BENJAMIN T . DNA sequence alterations in Hr-t deletion mutants of polyoma virus. Cell. 1979; 16(3):505-13. DOI: 10.1016/0092-8674(79)90025-4. View

5.
Bolen J, Consigli R . Differential adsorption of polyoma virions and capsids to mouse kidney cells and guinea pig erythrocytes. J Virol. 1979; 32(2):679-83. PMC: 353601. DOI: 10.1128/JVI.32.2.679-683.1979. View